title: Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline.
abstract: We present a case of Rhodococcus equi primary retroperitoneal abscesses without pulmonary involvement in an immunocompromised patient with severe nephrotic syndrome. No risk factors for exposure to R. equi were present. The infection was successfully treated with long-term combination antibiotic treatment including linezolid and tigecycline.
authors.affiliation: Department of Tropical and Infectious Diseases, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy. gianluca.russo@uniroma1.it
authors.forename: Gianluca
authors.initials: G
authors.lastname: Russo
authors.forename: Miriam
authors.initials: M
authors.lastname: Lichtner
authors.forename: Martina
authors.initials: M
authors.lastname: Carnevalini
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Mascellino
authors.forename: Fabio
authors.initials: F
authors.lastname: Mengoni
authors.forename: Alessandra
authors.initials: A
authors.lastname: Oliva
authors.forename: Ginevra Azzurra
authors.initials: GA
authors.lastname: Miccoli
authors.forename: Marco
authors.initials: M
authors.lastname: Iannetta
authors.forename: Vito
authors.initials: V
authors.lastname: Trinchieri
authors.forename: Anna Paola
authors.initials: AP
authors.lastname: Massetti
authors.forename: Claudio Maria
authors.initials: CM
authors.lastname: Mastroianni
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Vullo
mesh_terms: D018784:Abdominal Abscess / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use*; D000193:Actinomycetales Infections / Q000150:complications / Q000188:drug therapy*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D016867:Immunocompromised Host; D007275:Injections, Intravenous; D000069349:Linezolid; D008297:Male; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000150:complications*; D023303:Oxazolidinones / Q000008:administration & dosage / Q000627:therapeutic use*; D012187:Retroperitoneal Space / Q000473:pathology; D016929:Rhodococcus equi; D000078304:Tigecycline; D016896:Treatment Outcome
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000078304:Tigecycline; D008911:Minocycline; D000069349:Linezolid